| Impact of interleukin-17 inhibitor therapy on arterial intima-media thickness among severe psoriatic patients ÉA Piros, Á Szabó, F Rencz, V Brodszky, K Szalai, N Galajda, ... Life 11 (9), 919, 2021 | 19 | 2021 |
| Seroconversion after anti‐SARS‐CoV‐2 mRNA vaccinations among moderate‐to‐severe psoriatic patients receiving systemic biologicals—Prospective observational cohort study EA Piros, O Cseprekál, A Görög, B Hidvégi, M Medvecz, Z Szabo, ... Dermatologic Therapy 35 (5), e15408, 2022 | 9 | 2022 |
| Reducing cardiovascular risk in immune‐mediated inflammatory diseases: Tumour necrosis factor inhibitors compared to conventional therapies—A systematic review and meta‐analysis NÁ Galajda, FA Meznerics, P Mátrai, P Fehérvári, AS Lengyel, ... Journal of the European Academy of Dermatology and Venereology 38 (6), 1070-1088, 2024 | 4 | 2024 |
| Deucravacitinib shows superior efficacy and safety in cutaneous lupus erythematosus compared to various biologics and small molecules–A systematic review and META-analysis LA Bokor, K Martyin, M Krebs, NÁ Galajda, FA Meznerics, B Szabó, ... Autoimmunity Reviews, 103723, 2024 | | 2024 |
| Safety and Efficacy Analysis of Targeted and Immune Combination Therapy in Advanced Melanoma—A Systematic Review and Network Meta-Analysis AS Lengyel, FA Meznerics, NÁ Galajda, N Gede, T Kói, AA Mohammed, ... International Journal of Molecular Sciences 25 (23), 12821, 2024 | | 2024 |
| IL-23/Th-17 pathway: a possible common link between psoriasis and cardiometabolic comorbidities. NÁ Galajda, A Éva, K Szalai, A Lukács, B Hon-Balla, MV Kolonics, ... | | 2023 |
| IL-23/Th-17 útvonal: egy lehetséges közös nevező a pikkelysömör és kardiometabolikus társbetegségeinek kialakulásában NÁ Galajda, ÉA Piros, K Szalai, A Lukács, B Hon-Balla, MV Kolonics, ... Bőrgyógyászati és Venerológiai Szemle 99 (1), 17-24, 2023 | | 2023 |
| 381 Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals ÉA Piros, O Cseprekál, A Lukács, B Hidvégi, M Medvecz, Z Szabó, ... The Journal of Investigative Dermatology 142 (12), S246, 2022 | | 2022 |
| 047 Interleukin-17 inhibitor therapy reduces arterial intima-media thickness in severe psoriasis ÉA Piros, Á Szabó, F Rencz, V Brodszky, K Szalai, N Galajda, ... Journal of Investigative Dermatology 141 (10), S156, 2021 | | 2021 |
| Cardiovascular protection with TNF inhibitors NÁ Galajda, FA Meznerics, P Mátrai | | |
| Efficacy and Safety of Triple Therapy in Advanced Melanoma—a Systematic Review and Network Meta-Analysis AS Lengyel, LV Kemény, FA Meznerics, NÁ Galajda, N Gede, ... Available at SSRN 4765230, 0 | | |
